Chambal Fertilisers and Chemicals Limited

NSE:CHAMBLFERT.NS

475.05 (INR) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 43,461.849,332.326,430.443,485.753,855.255,892.835,986.782,962.185,867.572,911.833,060.447,433.344,786.135,395.216,407.638,726.439,869.432,186.719,690.938,320.435,661.428,711.126,936.92228,072.125,081.122,114.5
Cost of Revenue 24,254.930,310.815,468.924,374.934,172.836,358.922,087.159,76863,118.852,06918,556.530,030.728,104.120,952.78,355.323,324.224,177.718,875.39,906.922,936.720,966.816,325.213,972.39918,204.916,081.713,559.7
Gross Profit 19,206.919,021.510,961.519,110.819,682.419,533.913,899.623,194.122,748.720,842.814,503.917,402.616,68214,442.58,052.315,402.215,691.713,311.49,78415,383.714,694.612,385.912,964.5239,867.28,999.48,554.8
Gross Profit Ratio 0.4420.3860.4150.4390.3650.3490.3860.280.2650.2860.4390.3670.3720.4080.4910.3980.3940.4140.4970.4010.4120.4310.4810.3510.3590.387
Reseach & Development Expenses 00000000000000000000000000
General & Administrative Expenses 00000000000000000000000000
Selling & Marketing Expenses 00000000000000000000000000
SG&A 12,137.912,323.710,077.312,263532.7539.812,296.416,015.217,804.514,465.612,06911,1268,857.18,174.55,598.8429.8437.2433.3676.5373.1471.3464.4596.9302.2400.8396.3
Other Expenses 0511.5629.4954.6817.689.4413.1228.6888.4147.5-280.5188.917374.9-581.5-112522.1274.3-705.274.3448.5258.3477.989-986766.4188.9
Operating Expenses 12,137.912,323.710,077.313,617.214,316.713,972.413,544.417,274.719,085.915,669.611,430.612,336.910,065.39,364.25,3018,146.38,989.98,117.76,787.29,291.49,885.38,641.69,209.4276,454.37,086.26,426.1
Operating Income 7,0696,697.8884.27,006.66,183.35,561.5732.86,146.14,891.55,173.22,863.85,065.76,616.75,078.32,751.37,255.96,701.85,193.72,996.86,092.34,809.33,744.33,755.0963,412.91,913.22,128.7
Operating Income Ratio 0.1630.1360.0330.1610.1150.10.020.0740.0570.0710.0870.1070.1480.1430.1680.1870.1680.1610.1520.1590.1350.130.1390.1220.0760.096
Total Other Income Expenses Net 787.2109.4269.51,148.3445.8-403.6-668.9-974379.2-61.2261.41,040.1728.7444.82,794.8-433.9-77.3-591-1,519.2-977.7-929.8-1,033.4-2,656.591-1,027.2652.3152.1
Income Before Tax 7,856.26,807.21,153.76,641.95,811.55,157.963.94,945.44,0425,1123,334.76,105.87,345.45,523.15,546.16,8226,624.54,602.71,477.65,114.63,879.52,710.91,098.5052,385.72,565.52,280.8
Income Before Tax Ratio 0.1810.1380.0440.1530.1080.0920.0020.060.0470.070.1010.1290.1640.1560.3380.1760.1660.1430.0750.1330.1090.0940.0410.0850.1020.103
Income Tax Expense 2,492.62,675.3290.62,047.92,001.91,771.9-875.91,706.31,300.11,694.9896.71,754.12,287.71,709.9128.62,114.52,257.41,618.9-403285.371.31,066.5256.241747.7754.9730.6
Net Income 5,363.74,483.6967.84,594.13,809.73,386.49413,240.32,742.73,418.22,435.74,350.65,059.23,814.34,478.94,710.64,370.32,987.81,975.54,803.33,8261,657.1918.2381,611.11,814.71,558.2
Net Income Ratio 0.1230.0910.0370.1060.0710.0610.0260.0390.0320.0470.0740.0920.1130.1080.2730.1220.110.0930.10.1250.1070.0580.0340.0570.0720.07
EPS 13.3911.192.5111.049.158.142.267.796.598.215.8510.4512.169.1610.7611.3210.57.184.7511.549.193.982.213.884.363.74
EPS Diluted 13.3911.192.5111.049.158.142.267.796.598.215.8510.4512.169.1610.7611.3210.57.184.7511.549.193.982.213.884.363.74
EBITDA 8,701.58,031.72,294.47,239.36,967.76,422.51,527.56,928.95,333.46,081.33,857.36,016.37,541.75,886.66,408.17,860.97,942.16,175.82,619.26,899.26,024.14,787.94,887.2562,594.32,900.62,916
EBITDA Ratio 0.20.1520.0630.1790.1310.1160.0410.0830.0660.0870.1310.150.1860.1850.210.2080.2050.1950.0770.1810.1720.1670.1810.1040.1310.132